These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 30229899)
1. MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene. Zhu J; Zhu DQ; Zhang Y; Liu QM; Wang PC; Li HZ; Ma X; Zhang X J Cell Physiol; 2019 Mar; 234(3):2581-2592. PubMed ID: 30229899 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells. Sun M; Guo S; Yao J; Xiao Y; Sun R; Ma W; Dong Z J Cell Biochem; 2019 Feb; 120(2):1894-1902. PubMed ID: 30187954 [TBL] [Abstract][Full Text] [Related]
3. Non-coding RNA 886 promotes renal cell carcinoma growth and metastasis through the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway. Lei J; Xiao JH; Zhang SH; Liu ZQ; Huang K; Luo ZP; Xiao XL; Hong ZD Mol Med Rep; 2017 Oct; 16(4):4273-4278. PubMed ID: 28765891 [TBL] [Abstract][Full Text] [Related]
4. The IGF-I/JAK2-STAT3/miR-21 signaling pathway may be associated with human renal cell carcinoma cell growth. Su Y; Zhao A; Cheng G; Xu J; Ji E; Sun W Cancer Biomark; 2017 Jul; 19(3):289-296. PubMed ID: 28453463 [TBL] [Abstract][Full Text] [Related]
5. Suppression of lncRNA HOTAIR alleviates RCC angiogenesis through regulating miR-126/EGFL7 axis. Guo YP; Wang ZF; Li N; Lei QQ; Cheng Q; Shi LG; Zhou SL; Wang XH; Sun Y; Kong LF Am J Physiol Cell Physiol; 2021 May; 320(5):C880-C891. PubMed ID: 33502949 [TBL] [Abstract][Full Text] [Related]
6. CircRNA SCARB1 Promotes Renal Cell Carcinoma Progression Via Mir- 510-5p/SDC3 Axis. Sun J; Pan S; Cui H; Li H Curr Cancer Drug Targets; 2020; 20(6):461-470. PubMed ID: 32271695 [TBL] [Abstract][Full Text] [Related]
7. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase. Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468 [TBL] [Abstract][Full Text] [Related]
8. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway. Deng H; Gong X; Ji G; Li C; Cheng S Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma. Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475 [TBL] [Abstract][Full Text] [Related]
10. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway. Hong X; Yu JJ Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490 [TBL] [Abstract][Full Text] [Related]
11. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH. Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683 [TBL] [Abstract][Full Text] [Related]
12. miR-206 inhibits renal cell cancer growth by targeting GAK. Wei C; Wang S; Ye ZQ; Chen ZQ J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3. Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP. Liu S; Yang Y; Wang W; Pan X J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963 [TBL] [Abstract][Full Text] [Related]
15. In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2. Barclay JL; Kerr LM; Arthur L; Rowland JE; Nelson CN; Ishikawa M; d'Aniello EM; White M; Noakes PG; Waters MJ Mol Endocrinol; 2010 Jan; 24(1):204-17. PubMed ID: 19884384 [TBL] [Abstract][Full Text] [Related]
16. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway. Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R. Wang X; Li H; Cui L; Feng J; Fan Q Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875 [TBL] [Abstract][Full Text] [Related]
18. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis. Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway. Liu X; Gao X; Zhang W; Zhu T; Bi W; Zhang Y IUBMB Life; 2018 Jan; 70(1):81-91. PubMed ID: 29281186 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma. Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]